Trimi vs Hers: Compounded Semaglutide vs Wegovy Options
Trimi vs Hers: quick verdict
Trimi is centered on compounded semaglutide and tirzepatide with flat pricing and free overnight shipping, while Hers focuses on FDA-approved brand-name GLP-1s such as Wegovy® with a personalized care team. Early verdict: choose Trimi if you want compounded pricing stability and free overnight shipping; choose Hers if you require FDA-approved, brand-name medication and an ongoing personalized care team.
Direct comparison: medication type and regulatory status
Trimi offers compounded semaglutide and tirzepatide prescribed by US-licensed clinicians. The source states that compounded medications are prepared per individual prescription and are not themselves FDA-approved. Hers offers FDA-approved Wegovy® (brand-name semaglutide) and markets name-brand GLP-1 options with the explicit note that Wegovy® is FDA-approved and not a compounded product. Both providers include regulatory notes that compounded medications are not FDA-approved when relevant.
Pricing and membership structure
Price differences are a core contrast. Trimi advertises compounded semaglutide from $99/month on an annual plan and tirzepatide at $125/month with one flat price that does not change as dose increases; Trimi highlights free overnight, temperature-controlled shipping and states “same price at every dose.” Hers lists Wegovy® from $149/month and injectable options from $199/month, but also indicates that an active Hers Weight Loss Membership is required and that total cost includes a membership fee billed separately. Hers notes that membership and medication are billed separately and that medication is not available without an active membership.
View Hers FDA-approved options
Shipping, refunds, and guarantees
Trimi lists free overnight shipping and states a 6-month money-back promise: “Follow your plan for 6 months, and if you don’t lose weight, you can request a refund. Terms apply.” Trimi also states “Not approved by our medical team? 100% automatic refund.” Hers does not advertise a comparable money-back promise in the captured evidence; Hers emphasizes name-brand medication and ongoing dose check-ins but does not supply an equivalent refund or automatic-approval refund statement in the provided source content.
Check Trimi shipping and refund terms
Clinical oversight and pharmacy sourcing
Trimi describes clinical oversight by licensed U.S. providers through Arora Health, led by Medical Director Dr. Sean Arora, MD, and states medication is compounded by state-licensed 503A pharmacies, including VialsRx and GreenwichRx, with a certificate of analysis available on request. Hers emphasizes a personalized care team with ongoing dose check-ins and offers FDA-approved brand-name GLP-1s; Hers also highlights that prescriptions and treatment availability are determined by licensed clinicians and that not all products are available in all states. Both note that treatment is subject to clinician review and eligibility.
Distinctive supported differences
The most distinctive, supported differences from the sources are:
- Medication type and approval: Trimi uses compounded medications; Hers offers FDA-approved, brand-name Wegovy® and other name-brand GLP-1s.
- Pricing model: Trimi advertises flat pricing that stays the same as dose increases and annual-plan monthly rates from $99; Hers lists medication starting prices but requires a membership and bills medication and membership separately.
- Shipping and refunds: Trimi provides free overnight, temperature-controlled shipping and a 6-month money-back promise plus an automatic refund if not approved by their medical team; Hers emphasizes personalized care and dose check-ins without a comparable refund claim in the captured evidence.
- Pharmacy sourcing and oversight: Trimi names its compounding pharmacies and a national clinical network; Hers focuses on FDA-approved brand drugs and a personalized care team.
Comparison table
| Criteria | Trimi | Hers |
|---|---|---|
| Medication type | Compounded semaglutide and tirzepatide | FDA-approved Wegovy® and other brand-name GLP-1s |
| Starting price (captured) | Semaglutide from $99/mo | Wegovy® pill from $149/mo; injectable from $199/mo |
| Pricing structure | Flat pricing that never rises as dose increases; annual plan pricing | Medication price listed; an active membership is required and billed separately |
| Shipping | Free overnight, temperature-controlled shipping | Shipping details not captured in provided evidence |
| Refunds / guarantees | 6-month money-back promise; 100% automatic refund if not approved by medical team | No comparable refund promise captured in the evidence |
| Clinical oversight | Licensed U.S. providers through Arora Health; named compounding pharmacies listed | Personalized care team with ongoing dose check-ins; treatment as determined by licensed clinicians |
What the evidence does not supply
The captured sources do not supply direct head-to-head efficacy data, comprehensive state-by-state availability specifics for each plan, or detailed insurance coverage terms. The article uses only the supplied statements and qualifiers.
Conclusion: Choose Trimi vs Hers
Choose Trimi if you prioritize compounded semaglutide or tirzepatide with flat pricing that stays the same as dose increases, free overnight shipping, named compounding pharmacies, and the specific refund promises captured in Trimi’s materials. Choose Hers if you prefer FDA-approved, brand-name Wegovy® and other name-brand GLP-1s with a personalized care team and ongoing dose check-ins, and you accept membership and separate medication billing as described in Hers’s materials.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →